Mads Hald Andersen

2 articles listing Mads Hald Andersen in Nature Communications, indexed by Paperzzz from Crossref and OSF.

1. Five-year clinical outcome and immune biomarkers of durable response from the MM1636 trial on IDO/PD-L1 vaccination and PD-1 blockade in first line metastatic melanoma Nature Communications
2. β-adrenergic signaling blockade attenuates metastasis through activation of cytotoxic CD4 T cells Nature Communications